Omega Diagnostics (ODX) Shares Plunged Up to 37% on Fundraising Confirmation

Trade Omega Diagnostics Shares Your capital is at risk
Simon Mugo
Updated: 31 Jan 2022

Key points:

  • Omega diagnostics shares fell up to 37% after confirming fundraising rumours.
  • Investors reacted negatively to the news, given the shares massive losses.
  • Omega shares have fallen 70.2% since the year started, and it's barely a month.

The Omega Diagnostics Group Plc (LON: ODX) share price plunged up to 37% after confirming that it was considering raising cash from the markets via a share placement in the future.

new-recommended-broker-banner

The company was responding to rumours that it was considering such a move, which attracted a harsh reaction from investors.

Also Read: Best Healthcare Stocks in Singapore.

The diagnostics company recently announced the departure of its former CEO Colin King on 19 January 2022 with immediate effect. Also, it revealed that Bill Rhodes, a non-executive director, would step down from his role at the end of February.

Omega Diagnostics promoted Jag Grewal to the CEO role replacing King. Grewal is the current managing director of the company’s health and nutrition division. He has been with the company since 2011 and seems like an obvious choice for the company.

At the time, the company assured investors that it had a cash balance of over £2.5 million with a £2 million overdraft facility.

Investors were pleased to hear that Omega did not have any immediate need to raise capital. However, shortly after the announcement, rumours started circulating that the company was looking to raise additional capital from the markets.

Today’s confirmation extended Omega’s losses for the year to 70.2%, yet we are still in January, which makes me wonder where we will be as the year progresses.

Omega shares have lost over 70.2% of their value in four short weeks, and the company’s management is thinking of diluting existing shareholders much more via a new capital raise.

As an investor, I would stay away from the company until we get a sign that the situation is getting better. Meanwhile, better investment targets within the London Stock Exchange could generate better returns and protect investors capital.

*This is not investment advice. Always do your due diligence before making investment decisions.

Omega Diagnostics share price.

IG chart of Omega Diagnostics share price 31-01-2022
Source: IG

Omega Diagnostics share price fell 37.14% to trade at 6.60p, falling from Friday’s closing price of 10.50p.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .